Unknown

Dataset Information

0

Exosome-Based Regimen Rescues Endometrial Fibrosis in Intrauterine Adhesions Via Targeting Clinical Fibrosis Biomarkers.


ABSTRACT: Intrauterine adhesions (IUA), which is characterized by endometrial fibrosis, continue to be the most common cause of uterine infertility globally. Our work revealed that 3 fibrotic progression markers (Vimentin, COL5A2, and COL1A1) were significantly increased in the endometrium of IUA patients. Mesenchymal stem cell-derived exosomes (EXOs) have been recently revealed as a cell-free therapy for fibrosis diseases. Nevertheless, the application of EXOs is restricted by the short residency duration in the target tissue. To overcome this limitation, herein, we reported an exosome-based regimen (EXOs-HP) that thermosensitive poloxamer hydrogel possessed the ability to efficiently promote the residency duration of EXOs in the uterine cavity. By downregulating fibrotic progression markers (Vimentin, COL5A2, and COL1A1), EXOs-HP could significantly restore the function and structure of the injured endometrium in the IUA model. Our work provides the theoretical and experimental foundation of EXOs-HP in treating IUA, highlighting the clinical potential of topical EXOs-HP delivery system in IUA patients.

SUBMITTER: Lin Y 

PROVIDER: S-EPMC10021501 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exosome-Based Regimen Rescues Endometrial Fibrosis in Intrauterine Adhesions Via Targeting Clinical Fibrosis Biomarkers.

Lin Yifeng Y   Li Yaoshen Y   Chen Panpan P   Zhang Yanye Y   Sun Jiwei J   Sun Xiao X   Li Jiaqun J   Jin Jiani J   Xue Jinglei J   Zheng Junyan J   Jiang Xin-Chi XC   Chen Chuan C   Li Xiaoqing X   Wu Yiqing Y   Zhao Wei W   Liu Juan J   Ye Xiaohang X   Zhang Runju R   Gao Jianqing J   Zhang Dan D  

Stem cells translational medicine 20230301 3


Intrauterine adhesions (IUA), which is characterized by endometrial fibrosis, continue to be the most common cause of uterine infertility globally. Our work revealed that 3 fibrotic progression markers (Vimentin, COL5A2, and COL1A1) were significantly increased in the endometrium of IUA patients. Mesenchymal stem cell-derived exosomes (EXOs) have been recently revealed as a cell-free therapy for fibrosis diseases. Nevertheless, the application of EXOs is restricted by the short residency duratio  ...[more]

Similar Datasets

| S-EPMC9542425 | biostudies-literature
| S-EPMC11223343 | biostudies-literature
| S-EPMC7768166 | biostudies-literature
| S-EPMC9431258 | biostudies-literature
| S-EPMC7214885 | biostudies-literature
| S-EPMC11792338 | biostudies-literature
| S-SCDT-10_15252-EMMM_202317601 | biostudies-other
| S-EPMC9515604 | biostudies-literature
| S-EPMC10839775 | biostudies-literature